A trusted partner in bringing new medicines to life. Fast.
Whether you are a niche biotech firm or large pharma company, we provide services spanning the entire molecular life cycle to accelerate your time to market.
Sai Life Sciences
Sai Life Sciences is the fastest-growing contract research, development, and manufacturing organisation (CRDMO) among listed Indian peers (in terms of revenue CAGR as well as EBITDA CAGR from FY22 to FY24). As a pure-play, full-service CRDMO, we work with over 280 global innovator pharma and biotech companies to accelerate the discovery, development, and commercialisation of their NCE small molecule programmes.
Over the past 25 years, Sai Life Sciences has served a diverse set of programmes, consistently delivering value based on its quality and responsiveness. As of March 2024, we had 2845 employees across our facilities in India, UK, USA and Japan.
News
Sai Life Sciences receives EIRs from USFDA for India R&D & Manufacturing facilities
Sai Life Sciences, the fastest-growing Indian Contract Research, Development and Manufacturing Organization (CRDMO)[1], announced that it has received Establishment Inspection Reports (EIR) from the US Food and Drug Administration (USFDA) for its R&D (Unit II, Hyderabad), and Manufacturing (Unit IV, Bidar) sites in India. The General Good Manufacturing Practices (GMP) audit was conducted at the […]
Read more
News
Sai Life Sciences releases Sustainability Report 2024
Sai Life Sciences, the fastest-growing Indian Contract Research, Development and Manufacturing Organization (CRDMO)[1], published its Sustainability Report for 2023-2024. Aligned with the Global Reporting Initiative (GRI) Universal Standards 2021 framework, this fifth edition of the Sustainability Report is based on the theme, ‘Synergising Sustainability, Performance and Growth.’ The full report can be read here. Making […]
Read more
Service
Chemistry, manufacturing and controls
For 25 years, we have consistently delivered on a diverse set of NCE development programs for our customers with a track record of bringing value based on quality, pricing and responsiveness. With a strong team of scientists and process engineers, we are up to any challenge involving complex chemical synthesis from route scouting, process development, scale-up to commercial scale. We make high quality APIs and intermediates that serve the highly regulated markets of USA, Europe and Japan. Our world-class manufacturing facilities are equipped with flexible and versatile infrastructure, tailored to fit the smaller volume but more complex chemistry coming out of the development pipelines today. And we are continuously investing in making it better.
Read more
Service
Discovery
Sai Life Sciences has been a trusted small molecule CRO partner helping innovator biotech and pharma companies accelerate their drug discovery journey from HIT to IND using creative chemistry supported by high quality Biology, DMPK, toxicology and cGMP scale-up services.
We are known to be responsive, flexible and cost-effective in delivering solutions tailored to suit the program requirements. As a testimony to our efforts, we have built strong relationships with clients spanning diverse therapeutic areas. Our strong and growing scientific team provides a "fully-integrated" service bringing the collective expertise of various teams together to develop a lead candidate.
Read more
Careers
Sai Life Sciences is the perfect workplace for ambitious individuals looking for a rewarding career within biology, chemistry and development of the medicines of tomorrow. Explore our open positions on the careers site and join our family of 2800+ strong Saimer family. We are always looking for new talent.
Read more
Facilities
Our R&D and manufacturing facilities located in US, UK and India are built to global standards and cater to an international set of clients. Several new facilities are planned for the near future and existing ones are expanding with state-of-the-art blocks. Our headquarters are in Hyderabad, right in the middle of India. We pride ourselves in a global reach.
Read more
News
Sai Life Sciences elevates Compound Management process with in-house software application, CORAL
Compound management is a vital function in pharmaceutical research. A streamlined environment can bring significant value to the process in the form of productivity and efficiency. Recognizing the importance of this function, we have made our Compound Management suite for Discovery services smarter with the introduction of an in-house software application, Compound Organization and Registration […]
Read more
News
Sai Life Sciences inducts 96 trainees across campuses in India
“I just got my first pair of safety shoes and I’m thrilled! Exploring the facility for the first time is such a joy!” – Spurthi R, Trainee, Medicinal Chemistry, Shamirpet. Ushering in a season of new beginnings, we welcomed 96 trainees across our campuses in India. These young individuals have been selected from eight colleges […]
Read more
News
Sai Life Sciences releases its Sustainability Report 2023
Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO/ CDMO), released its Sustainability Report 2022-2023. Developed in accordance with the Global Reporting Initiative (GRI) Universal Standards 2021 framework, the fourth edition of the Sustainability report is based on the theme ‘Steadfast on Sustainability,’ and it articulates the company’s commitment to sustainability […]
Read more
News
Sai Life Sciences augments DMPK capabilities to ace large-scale collaborations
To offer global big pharma clients cutting-edge, end-to-end drug metabolism and pharmacokinetics (DMPK) services, Sai Life Sciences, a global Contract Research, Development & Manufacturing Organization (CRO-CDMO), has expanded its DMPK capabilities. The expansion comprises the addition of 25,000 sq. ft. of state-of-the-art labs equipped with cutting-edge instrumentation enabling high-end automation. Complementing the expansion has been […]
Read more
News
Sai Life Sciences strengthens discovery leadership
Sai Life Sciences, a leading global contract research, development, and manufacturing organization, announces the addition of two seasoned professionals to its leadership team. Dr Atul Tiwari joins as Vice President – Discovery Strategy & Business, while Dr Santosh Kulkarni takes on the role of Vice President – Medicinal Chemistry. Their wealth of experience promises to […]
Read more
News
Sai Life Sciences wins Gold in Brandon Hall Group’s Excellence in Technology Awards
Sai Life Sciences won Gold in Brandon Hall Group’s Excellence in Technology Awards in the ‘Best Advance in Content Authoring Technology’ category. Sai Life Sciences was recognized for the use of UL Create Tool, an easy-to-use, cloud-based authoring tool from UL Solutions, for making the learning process seamless and effective for all. The company utilized […]
Read more
News
Sai Life Sciences enters its Silver Jubilee year; surpasses vision of 25 commercial molecules by 2025
Sai Life Sciences entered its Silver Jubilee year with aplomb, surpassing its vision of supporting global innovator partners in bringing 25 new medicines to market by 2025. The company crossed this milestone two years ahead of schedule and is poised to sustain this momentum on the back of a strong portfolio of molecules at various […]
Read more
News
Sai Life Sciences joins Science Based Targets initiative (SBTi), commits to fight climate change with Science
To help combat climate change, Sai Life Sciences, a global Contract Research, Development & Manufacturing Organization (CRO-CDMO), announced joining Science Based Targets initiative (SBTi), a global body enabling businesses to set ambitious emission reduction targets in line with the latest climate science. Accordingly, it has committed to set near-term company-wide emission reductions in line with […]
Read more
News
Sai Life Sciences reaffirms commitment to Sustainability, charts out SDGs to be achieved by FY27
On the World Environment Day 2023, Sai Life Sciences, a global Contract Research, Development & Manufacturing Organization (CRO-CDMO), announced its renewed Sustainable Development Goals (SDG) charting out the roadmap to achieve specific environmental, social and governance (ESG) targets by the financial year ending March 31, 2027. Making the announcement, Krishna Kanumuri, CEO & Managing Director, […]
Read more
News
Sai Life Sciences opens SSRL, a dedicated research facility for Schrödinger, at its Hyderabad R&D Campus
• Fully equipped labs with 75-member team set-up and made operational in <100 days Sai Life Sciences, one of India’s fastest growing global Contract Research, Development & Manufacturing Organisations (CRO-CDMO), today announced the opening of Sai Schrödinger Research Laboratories (SSRL) at its R&D campus in Hyderabad, India. The facility was inaugurated by Dr. Karen Akinsanya, […]
Read more
News
Sai Life Sciences and NIIT Foundation partner to create livelihood opportunities for underserved communities in Hyderabad
Sai Life Sciences, one of India’s fastest growing Contract Research, Development & Manufacturing Organizations (CRO-CDMO), today announced entering into an agreement with NIIT Foundation, a not-for-profit education society, to implement youth career development programs for underserved communities in Hyderabad, Telangana. As part of the agreement, NIIT Foundation will develop and run multiple courses, and provide […]
Read more
News
Sai Life Sciences sets up GMP Kilo Lab in Alderley Park, Manchester, UK
Sai Life Sciences today announced the setting up of a GMP Kilo Lab at its facility in Alderley Park, Manchester, UK. The new GMP Kilo Lab will enable Sai Life Sciences to offer drug substance and intermediates supplies ranging from gram to kilogram quantities to meet customer clinical requirements at an accelerated pace. Making the […]
Read more
News
Sai Life Sciences opens new High-Potency API Manufacturing facility at its Bidar Campus
• Designed and validated to handle high potent molecules less than 1 μg/m3 containment• First commercial production batch has commenced Sai Life Sciences, one of India’s fastest growing Contract Research, Development & Manufacturing Organizations (CRO-CDMO), today announced the opening of a new High-Potency API (HPAPI) manufacturing facility at its cGMP API Manufacturing campus in Bidar, […]
Read more